Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Broilers as a source of quinolone-resistant and extraintestinal pathogenic Escherichia coli in the Czech Republic

I. Literak, T. Reitschmied, D. Bujnakova, M. Dolejska, A. Cizek, J. Bardon, L. Pokludova, P. Alexa, D. Halova, I. Jamborova,

. 2013 ; 19 (1) : 57-63.

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc14040997
E-resources Online Full text

NLK ProQuest Central from 2000-06-01 to 2018-12-31
Health & Medicine (ProQuest) from 2000-06-01 to 2018-12-31
Public Health Database (ProQuest) from 2000-06-01 to 2018-12-31

Links

PubMed 23020862
DOI 10.1089/mdr.2012.0124
Knihovny.cz E-resources

Extraintestinal Escherichia coli infections are associated with extraintestinal pathogenic E. coli (ExPEC) strains. A total of 114 E. coli isolates were characterized regarding their antimicrobial resistance in a prospective study of 319 broilers from 12 slaughterhouses in the Czech Republic, a European Union member, during 2008. PCR-based assays to define ExPEC-associated traits were performed in resistant strains. Consumption of antimicrobial drugs by poultry in the Czech Republic was also analyzed. Antibiotic resistance was detected in 82% of isolates. Resistance to nalidixic acid and ciprofloxacin was predominant. Plasmid-mediated quinolone resistance genes, qnrB19 and qnrS1, were detected in 1 and 3 of 93 resistant isolates, respectively. Twenty-three percent of resistant isolates were considered as ExPEC. In total, 972 kg of flumequine, enrofloxacin, and difloxacin were used in poultry in the Czech Republic during 2008. High prevalence of broilers with ciprofloxacin-resistant E. coli isolates was linked to consumption of quinolones in poultry. Broilers may comprise an important vehicle for community-wide dissemination of fluoroquinolone-resistant E. coli and ExPEC. Withdrawal of fluoroquinolones from use in chicken production should be seriously considered in the Czech Republic and the European Union as well.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14040997
003      
CZ-PrNML
005      
20140114101952.0
007      
ta
008      
140107s2013 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1089/mdr.2012.0124 $2 doi
035    __
$a (PubMed)23020862
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Literak, Ivan
245    10
$a Broilers as a source of quinolone-resistant and extraintestinal pathogenic Escherichia coli in the Czech Republic / $c I. Literak, T. Reitschmied, D. Bujnakova, M. Dolejska, A. Cizek, J. Bardon, L. Pokludova, P. Alexa, D. Halova, I. Jamborova,
520    9_
$a Extraintestinal Escherichia coli infections are associated with extraintestinal pathogenic E. coli (ExPEC) strains. A total of 114 E. coli isolates were characterized regarding their antimicrobial resistance in a prospective study of 319 broilers from 12 slaughterhouses in the Czech Republic, a European Union member, during 2008. PCR-based assays to define ExPEC-associated traits were performed in resistant strains. Consumption of antimicrobial drugs by poultry in the Czech Republic was also analyzed. Antibiotic resistance was detected in 82% of isolates. Resistance to nalidixic acid and ciprofloxacin was predominant. Plasmid-mediated quinolone resistance genes, qnrB19 and qnrS1, were detected in 1 and 3 of 93 resistant isolates, respectively. Twenty-three percent of resistant isolates were considered as ExPEC. In total, 972 kg of flumequine, enrofloxacin, and difloxacin were used in poultry in the Czech Republic during 2008. High prevalence of broilers with ciprofloxacin-resistant E. coli isolates was linked to consumption of quinolones in poultry. Broilers may comprise an important vehicle for community-wide dissemination of fluoroquinolone-resistant E. coli and ExPEC. Withdrawal of fluoroquinolones from use in chicken production should be seriously considered in the Czech Republic and the European Union as well.
650    _2
$a zvířata $7 D000818
650    _2
$a antibakteriální látky $x farmakologie $7 D000900
650    _2
$a antiinfekční látky $x farmakologie $7 D000890
650    12
$a kur domácí $7 D002645
650    _2
$a mnohočetná bakteriální léková rezistence $7 D024901
650    _2
$a Escherichia coli $x účinky léků $x izolace a purifikace $7 D004926
650    _2
$a infekce vyvolané Escherichia coli $x epidemiologie $x mikrobiologie $x veterinární $7 D004927
650    _2
$a maso $x mikrobiologie $7 D008460
650    _2
$a fylogeneze $7 D010802
650    _2
$a prospektivní studie $7 D011446
650    _2
$a chinolony $x farmakologie $7 D015363
650    _2
$a faktory virulence $x genetika $7 D037521
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Reitschmied, Tomas $u -
700    1_
$a Bujnakova, Dobroslava $u -
700    1_
$a Dolejska, Monika $u -
700    1_
$a Cizek, Alois $u -
700    1_
$a Bardon, Jan $u -
700    1_
$a Pokludova, Lucie $u -
700    1_
$a Alexa, Pavel $u - $7 gn_A_00003891
700    1_
$a Halova, Dana $u -
700    1_
$a Jamborova, Ivana $u -
773    0_
$w MED00008749 $t Microbial drug resistance (Larchmont, N.Y.) $x 1931-8448 $g Roč. 19, č. 1 (2013), s. 57-63
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23020862 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140107 $b ABA008
991    __
$a 20140114102656 $b ABA008
999    __
$a ok $b bmc $g 1005393 $s 839509
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 19 $c 1 $d 57-63 $i 1931-8448 $m Microbial drug resistance $n Microb Drug Resist $x MED00008749
LZP    __
$a Pubmed-20140107

Find record

Citation metrics

Archiving options